Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 136

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 136
---
. The registration statement was declared effective on August 31, 2023.2022 Private PlacementOn August 8, 2022, we entered into an agreement to sell 16.1 million shares of our common stock in a private placement at a purchase price of $3.10 per share (“2022 Private Placement”). In addition, as a component of the 2022 Private Placement, we agreed to sell 8.5 million pre-funded warrants to purchase shares of our common stock at a purchase price of $3.0999 per share. The pre-funded warrants have an exercise price of $0.0001 per share. The total net proceeds from the sale of the common stock and pre-funded warrants was $75.1 million (net of $1.4 million in issuance costs). The 2022 Private Placement closed on August 10, 2022. In October 2022, we filed a registration statement with the SEC to register for resale 24.6 million shares of our common stock. The registration statement was declared effective on October 18, 2022.Common Stock Reserved for Future Issuance Shares of our common stock reserved for future issuance as of December 31, 2024 were as follows (in thousands): 

        Number of

        Shares

        Stock options outstanding

        26,082

        Restricted stock units outstanding

        1,981

        Shares available for future grants under the Amended & Restated 2007 Equity Incentive Plan

        12,125

        Shares of common stock reserved under the Employee Stock Purchase Plan

        921

        Shares of common stock underlying warrants

        298

        Shares of common stock underlying convertible notes outstanding (see Note 8)

        9,819

        Total shares reserved for future issuance

        51,226

92

10.Equity Incentive Plans Employee Stock Purchase PlanIn 1997, our stockholders approved our Employee Stock Purchase Plan (“ESPP”) at which time a maximum of 10,000 shares of common stock were available for issuance. In December 2007, May 2009, June 2011, May 2014, May 2015, June 2016, June 2017, June 2019, June 2021, May 2022, June 2023 and June 2024, our stockholders authorized increases in the number of shares reserved for issuance under the ESPP by 5